Open access
Jul 2026
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
RATIONALE Follow-up of pre-licensure trial participants potentially informs a vaccine's long-term safety profile. DESIGN This prospective study enrolled participants from the first clinical trials of ChAdOx1 nCoV-19 vaccine, many of whom subsequently received COVID-19 vaccines in the UK vaccination programme. Serious...
Narges Ebrahimi, Philip de Whalley, Nasir Kanji et al.
· Vaccine · 0 citations